PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
Jordi Remón, Nicolas Girard, Silvia Novello, Javier de Castro, L. Bigay-Gamé, Reyes Bernabé, Laurent Greillier, Joaquín Mosquera, Sophie Cousin, Óscar Juan, Miguel Sampayo, Benjamin Besse
Topics & Concepts
LenvatinibPembrolizumabMedicineThymomaThymic carcinomaInternal medicineOncologyAtezolizumabChemotherapyClinical endpointCarcinomaPhases of clinical researchCancerClinical trialImmunotherapyPathologyThyroid cancerMyasthenia Gravis and ThymomaNeuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases